Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG
Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG
Active, not recruiting · NCT05610891 · Registry updated 2026-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, malignant glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 1 | 2026-10-01 | NCT05610891 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cellectar Biosciences, Inc. | 5 |
| National Cancer Institute (NCI) | 3015 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Hospital of Philadelphia | Philadelphia | United States | 434 |
| Cincinnati Children's Hospital Medical Center | Cincinnati | United States | 405 |
| Hospital for Sick Children | Toronto | Canada | 76 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Stanford University | Palo Alto | United States | 161 |
| Texas Children's Cancer Center, Baylor College of Medicine | Houston | United States | 1 |
| University of Wisconsin, Carbone Cancer Center | Madison | United States | 2 |
| UT Southwestern Medical Center | Dallas | United States | 210 |